XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

42,405 resources

By Version

R2: 0
R2B: 0
R3: 2,217
R4: 26,023
R4B: 2,734
R5: 11,207
R6: 224

By Realm

none: 3,411
au: 272
be: 387
ca: 138
ch: 1,482
cl: 469
cr: 45
cz: 384
de: 190
dk: 88
ee: 155
eu: 1,173
fi: 87
fr: 120
in: 29
it: 181
kr: 5
nl: 929
no: 26
nz: 79
pl: 83
se: 22
stt: 116
us: 17,481
uv: 14,773
vn: 107
other: 7

Start Prev Rows 26200 - 26400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.35	C2S Mental Health Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.36	C2S Mental Health Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.38	C2S Opioids	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.39	C2S Opioids	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.4	C2S Alcohol Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.40	C2S Opioids	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.42	C2S Opioids	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.43	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.44	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.45	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.46	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.47	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.48	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.49	C2S Sexuality and reproductive health information sensitivity	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.5	C2S Alcohol Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.51	C2S Tobacco Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.52	C2S Tobacco Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.53	C2S Tobacco Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.54	C2S Tobacco Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.55	C2S Substance Use Information Sensitivity	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.56	C2S Substance Use Information Sensitivity	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.58	C2S Sensitive Categories	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.59	C2S Opioids	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.6	C2S Amphetamine Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.60	C2S HIV/AIDS information Sensitivity	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.65	Test C2S Alcohol Use Disorders	active	2019-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.67	Test C2S HIV/AIDS Information Sensitivity	active	2019-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.7	C2S Amphetamine Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.8	C2S Amphetamine Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1142.9	C2S Amphetamine Use Disorders	active	2016-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.10	Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1002	Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1012	S. Typhi Infection (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1016	S. Paratyphi Infection (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1017	S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1021	Dark Urine (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1022	Acute Onset [Qualifier Value] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1024	Acute Viral Hepatitis (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1027	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1029	Listeriosis [Listeria species] (Organism or Substance in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1030	Meningitis [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1032	Encephalitis [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1033	Encephalitis [Unspecified Cause] (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1035	Indeterminate or Equivocal Lab Result Value	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1037	Smoking Status [Current Nonsmoker] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1040	Organisms (Tests by Unspecified Method)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1041	Organisms (Tests by Culture and Identification)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1044	Candida auris Infection (Tests for Candida auris by Culture and Identification Method)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1045	Candida auris Infection (Tests for Candida auris Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1047	Parkinson’s disease (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1048	Parkinson’s disease (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1049	Parkinsonism [Secondary] (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1050	Parkinsonism [Secondary] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1065	Consciousness [Decreased Level] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1071	Drug Use [IV Evidence] (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1072	Miosis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1076	Opioid Overdose and Poisoning (Tests for Opioids [Quantitative])	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1083	Rash [Pustular Vesicular] (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1084	Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1090	Syphilis [Congenital] (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1091	Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1092	Congenital heart disease (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1093	Hearing impairment (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1095	Microcephaly (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1096	Developmental delay (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1099	Congenital heart disease (ICD10CM)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1100	Hearing impairment (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1104	Developmental delay (ICD10CM)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1106	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.112	Tetanus (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1130	Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1131	Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1138	Staphylococcus Aureus (Tests by Culture and Identification Method)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1139	VISA/VRSA (Tests for Vancomycin Resistance Gene)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1145	Resistant Lab Result Value	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1148	Tests for Vancomycin Susceptibility [Ord]	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1149	Proteinuria (Tests for Total Protein in 24H Urine)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.115	Mumps (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1150	Thrombocytopenia (Tests for Platelets [#/volume] in Blood)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1156	Staphylococcus aureus (Organism or Substance in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1169	Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.117	Mumps (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1180	Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1186	Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative])	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1188	Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1196	Anthrax (Tests for Bacillus cereus by Culture and Identification Method)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1197	Cervical Lymphadenitis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1207	CRE (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1212	Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1213	NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1214	Carbapenemase resistance mechanism (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1215	Tests for carbapenemase production	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1216	Tests for carbapenemase resistance mechanism	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1217	Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1218	Tests for carbapenem susceptibility [Ertapenem]	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1219	Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1220	NU_Tests for Enterobacteriaceae species by Culture and Identification Method	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1224	Therapeutic Response to Medication [Improved]	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1225	Altered Mental Status (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1230	Eschar (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1231	Hypotension (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1233	Localized Edema (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1234	Localized Edema (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1237	Tachycardia (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1238	Tachycardia (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1239	RCKMS Conditions (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.124	Poliomyelitis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1240	Maternal Condition Puerperium (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1242	Non pestis Yersiniosis Infection (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1244	Blastomycosis (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1246	Blastomycosis (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1249	Blastomycosis (Tests for Blastomyces species by Culture and Identification Method)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1250	Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1251	Blastomycosis (Tests for Blastomyces species Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1252	Blastomycosis (Tests for Blastomyces species Antibody)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1253	Blastomycosis (Tests for Blastomyces species Antigen)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1265	Fatigue (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1269	Tuberculosis [Latent Infection] (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1274	Histoplasmosis (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1275	Histoplasmosis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1281	Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1294	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1295	Seizure [Unspecified Cause] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1298	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1299	Seizure [Unspecified Cause] (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.130	Influenza (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1304	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1305	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1306	Body Temperature (Vital Sign)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1307	Respiratory Rate (Vital Sign)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1309	RSV (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1310	RSV (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1312	RSV (Tests for RSV Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1314	Wheezing (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1317	Bronchiolitis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1325	Tobacco Use and Exposure (Social History)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1330	Tobacco Smoking Status [Current] (Social History) (LOINC)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1335	Hospitalized [Inpatient] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1336	Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1337	Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1340	Prion Disease (Tests for 14_3_3 Protein)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1341	Prion Disease (Tests for Abnormal Prion Protein)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1349	Cerebrospinal Fluid (Specimen Type) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.135	Chronic Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1350	Endocervical (Specimen Type) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1351	Tissue (Specimen Type) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1352	Specimen from a Normally Sterile Site (Specimen Type)(SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1353	Urethral Swab (Specimen Type) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1355	Wound (Specimen Type) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1359	Hepatitis E (Tests for hepatitis E virus IgM Antibody)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.136	Invasive Pneumococcal Disease (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1360	Hepatitis E (Tests for hepatitis E virus Antibody)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1363	Epiglottitis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1364	Organisms (Tests by Microscopic Observation by Gram Stain)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1369	Serum (Specimen Type) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1378	Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1379	Fish Poisoning (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1388	Occupational Asthma (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1389	Asthma (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1390	Asthma (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1391	Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1393	WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1400	Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1402	Cancer [Malignant Neoplasms] (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1403	Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1404	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1405	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1407	Cancer [Malignant Neoplasms] (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1418	Alpha gal syndrome (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1420	Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1422	Ptosis of Eyelid [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1423	Ptosis of Eyelid [Unspecified Cause] (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1424	Constipation [Unspecified Cause] (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1426	Intubation [Respiratory Tract] (Procedure) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1430	Infant Botulism (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1446	Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1447	MRSA (Disorders (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1449	Staphylococcus aureus infection (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.145	Varicella (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1450	Staphylococcus aureus infection (Disorders) (ICD10CM)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1452	MRSA (Tests by Culture and Identification Method)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1453	MRSA (Tests for Methicillin Resistance Gene)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1454	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1458	Tests for Cefoxitin Susceptibility [OrdQn]	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1459	Organisms (Tests in Blood by Culture and Identification)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1460	Bacteria (Tests in Blood by Culture and Identification Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1461	Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1462	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1463	VRE (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1464	VRE (Organism or Substance in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1465	VRE (Tests by Culture and Identification Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1466	Enterococcus species (Tests by Culture and Identification Method)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1468	Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1469	Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1470	Enterococcus species (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1471	Amebiasis (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1473	Amebiasis (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1476	Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1482	Norovirus (Tests for Norovirus Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.1485	Norovirus (Organism or Substance in Lab Results)	active	2024-01	us